US Stock MarketDetailed Quotes

PFE Pfizer

Watchlist
  • 26.860
  • -0.270-1.00%
Close Jan 8 16:00 ET
  • 26.850
  • -0.010-0.04%
Post 19:59 ET
152.22BMarket Cap35.81P/E (TTM)

Pfizer Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pfizer Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 14.362B--
--2024/Q4-- / 17.137B--
Oct 29, 20242024/Q317.702B / 14.865B--
Jul 30, 20242024/Q213.283B / 13.019B--
May 1, 20242024/Q114.879B / 13.923B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 14.362B--
--2024/Q4-- / 17.137B--
Oct 29, 20242024/Q317.702B / 14.865B--
Jul 30, 20242024/Q213.283B / 13.019B--
May 1, 20242024/Q114.879B / 13.923B--

Unlock Free Earnings Estimates

Pfizer Earnings Reports

  • Pfizer | 10-Q: Q3 2024 Earnings Report

    Nov 4, 2024 16:10 ET

  • Pfizer | 10-Q: Q2 2024 Earnings Report

    Aug 5, 2024 15:57 ET

  • Pfizer | 10-Q: Q1 2024 Earnings Report

    May 8, 2024 15:59 ET

  • Pfizer | 10-K: FY2023 Annual Report

    Feb 22, 2024 13:22 ET

    • Read more

    Trending US Stocks
    Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

    Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

    Symbol Mini Chart % Chg
    Toll Brothers
    TOL
    +2.56%
    Meritage Homes
    MTH
    +2.34%
    Taylor Morrison Home
    TMHC
    +1.58%
    D.R. Horton
    DHI
    +1.49%
    KB Home
    KBH
    +1.35%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 8, 2025

    Buy

    • Buy

      34.78%

    • Hold

      60.87%

    • Sell

      4.35%

    Price Target

    No Data

    Investment Theme Weight Loss Drugs
    Weight Loss Drugs
    Intraday+1.63%
    Cancer Research
    Cancer Research
    Intraday-0.60%
    Infectious Disease
    Infectious Disease
    Intraday-0.85%